Chiesi Belgium

We are an international company based in Parma, with more 80 years of experience and a strong focus on research, development, production and the commercialization of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas.

Chiesi combines the pioneering spirit of an SME (Small and Medium Enterprise) with the ambitions of a multinational. How do we succeed in doing this? Thanks to our team of passionate and resourceful professionals. Each and every day, they build on our exceptional results in a focused, credible and humble manner. We call this the Chiesi spirit.

In 2020, Chiesi reached the historic milestone of a turnover of more than 2 billion euro. This puts us on the list of the top 50 pharmaceutical companies..

The Belgian Chiesi site (affiliate of the Chiesi Group SA) was established in 2010. Our enthusiastic team is particularly focused on bringing our treatments to the Belgian patients. In close consultation with patients and medical professionals, we make our contribution to the improvement of health care.

The Belgian Chiesi site is recognizable for its:

• Focus on innovations – with a great deal of attention for R&D in the areas of neonatology, respiratory diseases, and stem cell and gene therapy.
• Proximity – through close collaboration with universities, patients and the medical community.
• Chiesi spirit – with a high-quality, personal and patient-oriented approach.